Kanilev is an injectable medication containing levocarnitine (L-carnitine), a naturally occurring amino acid derivative essential for energy production in the body. It plays a crucial role in transporting long-chain fatty acids into mitochondria, where they are oxidized to produce energy
Indications
Kanilev is prescribed for:
Primary Carnitine Deficiency: A genetic disorder leading to low carnitine levels.
Secondary Carnitine Deficiency: Often observed in patients with end-stage renal disease (ESRD) undergoing hemodialysis.
Acute Metabolic Deregulation: Conditions like hypoglycemia, hypoketotic hypoglycemia, or cardiomyopathy associated with carnitine deficiency.
Dosage & Administration
For ESRD Patients on Hemodialysis: Administer 10–20 mg/kg body weight as a slow IV bolus at the end of each dialysis session.
For Acute Metabolic Conditions: 50–100 mg/kg body weight daily, divided into 3–4 doses.
Maintenance Therapy: If initial IV therapy is effective, oral levocarnitine may be used post-dialysis sessions.
The exact dosage and duration should be determined by a healthcare professional based on individual patient needs.
Side Effects
Common side effects may include:
1.Nausea
2.Vomiting
3.Diarrhea
4.Injection site reactions (pain, swelling, redness)
5.Body odor
